Physician profile
John Ferrari
NPI 1417107814
$464.53
in general payments reported to CMS, 2019-2025
14 companies · $122 in 2025
The $122 reported for 2025 was more than what a typical Anesthesiology provider received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11.94 · 2020: $73.56 · 2022: $163 · 2023: $23.00 · 2024: $71.47 · 2025: $122.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $216.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $216.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimvie INC. | $113.53 | 2022 | |
| Chiesi USA, INC. | $90.14 | 2020-2022 | |
| Janssen Biotech, INC. | $49.72 | 2024-2025 | Tremfya, Stelara, Simponi |
| Novo Nordisk INC | $32.86 | 2020 | |
| Celltrion USA INC. | $32.80 | 2024-2025 | Vegzelma |
| Medline Industries LP | $23.00 | 2023 | |
| Ardelyx, INC. | $20.72 | 2025 | Ibsrela |
| Tandem Diabetes Care, INC. | $19.83 | 2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Lilly USA, LLC | $17.91 | 2025 | Omvoh |
| Terumo Medical Corporation | $17.48 | 2024 | Metacross Otw, Glidesheath Slender, Glidewire |
| Takeda Pharmaceuticals U.S.A., INC. | $14.34 | 2024 | Gattex |
| Kyowa Kirin, INC. | $13.90 | 2025 | |
| Merck Sharp & Dohme LLC | $11.94 | 2019 | |
| Ambu INC. | $6.36 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Ferrari listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.